Revised OIG's Provider Self-Disclosure Protocol, 27408 [2013-11050]
Download as PDF
<![CDATA[
27408
Federal Register / Vol. 78, No. 91 / Friday, May 10, 2013 / Notices
call 301–443–5260; or (3) send an email
to srogers@hrsa.gov.
Regulatory Affairs, Office of Inspector
General, (202) 619–1368.
Dated: May 3, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
Daniel R. Levinson,
Inspector General.
[FR Doc. 2013–11050 Filed 5–9–13; 8:45 am]
BILLING CODE 4152–01–P
[FR Doc. 2013–11087 Filed 5–9–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of Inspector General
[Docket Number OIG–1301–N2]
Revised OIG’s Provider Self-Disclosure
Protocol
Office of Inspector General
(OIG), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
issuance of the updated Provider SelfDisclosure Protocol (the SDP), originally
published in the Federal Register on
October 30, 1998 (63 FR 58399). In
1998, the Office of Inspector General
published the SDP to establish a process
for health care providers to voluntarily
identify, disclose, and resolve instances
of potential fraud involving the Federal
health care programs (as defined in
section 1128B(f) of the Social Security
Act (the Act), 42 U.S.C. 1320a–7b(f)).
The SDP provides guidance on how to
investigate this conduct, quantify
damages, and report the conduct to OIG
to resolve the provider’s liability under
OIG’s civil monetary penalty (CMP)
authorities.
Since the original publication, we
identified areas where additional
guidance would be beneficial to the
health care community and would
improve the efficient resolution of SDP
matters. To that end, we issued three
Open Letters to Health Care Providers in
2006, 2008, and 2009. Since the last
Open Letter, we continued to evaluate
our SDP process. We also solicited
comments about the SDP on June 18,
2012, and we received numerous
helpful comments from the public. On
the basis of our experience and the
comments we received, we have
decided to revise the SDP in its entirety
at this time. This revised SDP
supersedes and replaces the 1998
Federal Register Notice and the Open
Letters.
OIG has posted the full revision of the
SDP on its Web site: https://oig.hhs.gov/
compliance/self-disclosure-info/
index.asp.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Patrice S. Drew, Congressional and
VerDate Mar<15>2010
18:05 May 09, 2013
Jkt 229001
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development (NICHD); Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Child Health and
Human Development Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available. A
portion of this meeting will be closed to
the public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review and
discussion of grant applications.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the contact person listed below in
advance of the meeting.
Name of Committee: National Advisory
Child Health and Human Development
Council.
Date: June 6, 2013.
Open: June 6, 2013, 8:00 a.m. to 12:00 p.m.
Agenda: The agenda will include: 1) a
report by the Director, NICHD; 2) Report of
the Director, Division of Extramural
Research; 3) Review of Council Operating
Procedures; and 4) Other Business of the
Council.
Closed June 6, 2013, 1:00 p.m. to
Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Center Drive, C-Wing,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Yvonne T. Maddox, Ph.D.,
Deputy Director, Eunice Kenney Shriver
National Institute of Child Health, and
Human Development, NIH, 9000 Rockville
Pike MSC 7510, Building 31, Room 2A03,
Bethesda, MD 20892, (301) 496–1848.
Any interested person may file written
comments with the committee by forwarding
the statement to the contact person listed on
this notice. The statement should include the
name, address, telephone number, and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles,
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s home page: https://
www.nichd.nih.gov/about/advisory/nachhd/
Pages/index.aspx, where an agenda and any
additional information for the meeting will
be posted when available.
In order to facilitate public attendance at
the open session of Council, additional
seating will be available in the meeting
overflow rooms, Conference Rooms 7 and 8.
Individuals will also be able to view the
meeting via NIH Videocast. Please go to the
following link for Videocast access
instructions at: https://www.nichd.nih.gov/
about/advisory/nachhd/Pages/virtualmeeting.aspx.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment program, National
Institutes of Health, HHS).
Dated: May 3, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–11102 Filed 5–9–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SBIR Topic
304 ‘‘Development of Blood-based Methods
for the Detection of Cancer Recurrence in
Post-Therapy Breast Cancer Patients.
Date: June 4, 2013.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
E:\FR\FM\10MYN1.SGM
10MYN1
]]>Agencies
[Federal Register Volume 78, Number 91 (Friday, May 10, 2013)]
[Notices]
[Page 27408]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-11050]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of Inspector General
[Docket Number OIG-1301-N2]
Revised OIG's Provider Self-Disclosure Protocol
AGENCY: Office of Inspector General (OIG), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the issuance of the updated Provider
Self-Disclosure Protocol (the SDP), originally published in the Federal
Register on October 30, 1998 (63 FR 58399). In 1998, the Office of
Inspector General published the SDP to establish a process for health
care providers to voluntarily identify, disclose, and resolve instances
of potential fraud involving the Federal health care programs (as
defined in section 1128B(f) of the Social Security Act (the Act), 42
U.S.C. 1320a-7b(f)). The SDP provides guidance on how to investigate
this conduct, quantify damages, and report the conduct to OIG to
resolve the provider's liability under OIG's civil monetary penalty
(CMP) authorities.
Since the original publication, we identified areas where
additional guidance would be beneficial to the health care community
and would improve the efficient resolution of SDP matters. To that end,
we issued three Open Letters to Health Care Providers in 2006, 2008,
and 2009. Since the last Open Letter, we continued to evaluate our SDP
process. We also solicited comments about the SDP on June 18, 2012, and
we received numerous helpful comments from the public. On the basis of
our experience and the comments we received, we have decided to revise
the SDP in its entirety at this time. This revised SDP supersedes and
replaces the 1998 Federal Register Notice and the Open Letters.
OIG has posted the full revision of the SDP on its Web site: https://oig.hhs.gov/compliance/self-disclosure-info/index.asp.
FOR FURTHER INFORMATION CONTACT: Patrice S. Drew, Congressional and
Regulatory Affairs, Office of Inspector General, (202) 619-1368.
Daniel R. Levinson,
Inspector General.
[FR Doc. 2013-11050 Filed 5-9-13; 8:45 am]
BILLING CODE 4152-01-P
